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ORIGINAL ARTICLE

IMAGING

Diffusion-Weighted Imaging Reveals Distinct Patterns
of Cytotoxic Edema in Patients with Subdural Hematomas
David Robinson,1,* Natalie Kreitzer,2 Laura B. Ngwenya,3,4 Opeolu Adeoye,5 Daniel Woo,1
Jed Hartings,3,4 and Brandon Foreman1,4
Abstract
Subdural hematomas (SDHs) are increasingly common and can cause ischemic brain injury. Previous work
has suggested that this is driven largely by vascular compression from herniation, although this work was
done before the era of magnetic resonance imaging (MRI). We thus sought to study SDH-related ischemic
brain injury by looking at patterns of cytotoxic edema on diffusion-weighted MRI. To do so, we identiﬁed all
SDH patients at a single institution from 2015 to 2019 who received an MRI within 2 weeks of presentation.
We reviewed all MRIs for evidence of restricted diffusion consistent with cytotoxic edema. Cases were excluded if the restricted diffusion could have occurred as a result of alternative etiologies (e.g., cardioembolic
stroke or diffuse axonal injury). We identiﬁed 450 SDH patients who received an MRI within 2 weeks of presentation. Twenty-nine patients (*6.5% of all MRIs) had SDH-related cytotoxic edema, which occurred in
two distinct patterns. In one pattern (N = 9), patients presented as comatose with severe midline shift
and were found to have cytotoxic edema in the vascular territories of the anterior and posterior cerebral
artery, consistent with herniation-related vascular compression. In the other pattern (N = 19), patients
often presented as awake with less midline shift and developed cytotoxic edema in the cortex adjacent
to the SDH outside of typical vascular territories (peri-SDH cytotoxic edema). Both patterns occurred in 1
patient. The peri-SDH cytotoxic edema pattern is a newly described type of secondary injury and may involve direct toxic effects of the SDH, spreading depolarizations, or other mechanisms.
Keywords: ischemia; secondary insult; subdural hematoma

Introduction
Subdural hematomas (SDHs) are a major source of morbidity and mortality in the United States, leaving up to
50% of patients dead or disabled at 3 months.1 Whereas
other forms of intracranial hemorrhage are stable in incidence,2,3 SDHs are projected to become the most common neurosurgical condition by 2030.4,5 Much of this
rising incidence has been attributed to minor traumas in
an aging population with increased antithrombotic use.6
Apart from surgical decompression in appropriate patients, there are few evidence-based interventions to improve outcomes from this increasingly common disease.
Ischemic neuronal injury accounts, in part, for SDHassociated morbidity and mortality,7 although the mech-

anisms by which this occurs remain poorly understood.
Animal models have argued that SDHs directly cause ischemic injury to the underlying cortex through mechanisms like regional hypoperfusion, toxic effects from
blood breakdown products, and spreading depolarizations.8–12 A direct, clinically significant effect of SDHs
on the underlying cortex would have major therapeutic implications, given that it could provide a target for medical
interventions and help further clarify surgical indications.
In contrast to the animal data, work in human subjects
has not consistently identified a direct SDH-related effect. The largest study suggested that SDHs caused ischemic injury indirectly through herniation-related
compression of the posterior (PCA) and anterior cerebral
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arteries (ACA).13 This earlier work was limited by its use
of radionuclide imaging, a technique with limited sensitivity for smaller regions of ischemic injury.14 Diffusionweighted magnetic resonance imaging (MRI) is exquisitely
sensitive for even small areas of cytotoxic edema, an indicator of neuronal injury most commonly caused by ischemia.15 Cytotoxic edema is known to complicate
traumatic brain injury, although the potential mechanisms of this phenomenon have not been fully worked
out,16 and there has been no large systematic study of
MRI patterns of cytotoxic edema in SDH patients. We
thus sought to characterize the radiological and clinical
characteristics of SDH patients found to have cytotoxic
edema on MRI in the acute period.
Methods
Study design and participants
In this retrospective observational study, all patients presenting to a single level 1 trauma center from October
2015 through September 2020 were screened for incident
SDH presentations using discharge diagnosis codes from
the International Classification of Diseases, Tenth Revision (S06.5, I62.0). These codes have been previously
validated and reliably identify patients with SDHs of all
radiological acuities.17 From these incident SDH cases,
we identified all cases that met the following inclusion
criteria: 1) age >18 and 2) availability of MRI data within
2 weeks of SDH symptom onset. Patients who experienced acute symptomatic expansion of a previously diagnosed SDH were also included. Patients were enrolled
based upon clinical time of symptom onset irrespective
of radiological SDH characteristics. Patients with potential
neoplasms, infections, post-operative subdural collections,
or hemorrhages from arteriovenous malformations/
aneurysms were excluded. Patients who underwent surgery with any significant manipulation of the cortex
(e.g., clot extractions) were also excluded. Surgical decision making and medical management were at the discretion of the treating neurosurgeon.
All MRIs were obtained for clinical purposes at the
discretion of the treating physician; at our institution,
MRIs are typically obtained for the purpose of prognostication or evaluation of focal neurological deficits.
This study was approved by the local institutional review
board at the University of Cincinnati (Cincinnati, OH)
with a waiver from informed consent.
Data abstraction
For all identified patients, an electronic standardized case
report form was used to collect clinical data, including
demographics, labs, medical history, initial Glasgow
Coma Scale (GCS) scores, neurological examination
findings, surgical management/timing, and hospital complications including seizures. Data were abstracted by a
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single reviewer (D.R.), and 10% of data were doubleabstracted by a second reviewer to confirm accuracy of
the process. Initial computed tomography (CT) imaging
was reviewed for all patients in order to calculate SDH
volume18 and assess the radiological characteristics of
the SDHs in a standardized fashion as acute (homogeneous and hyperdense on the initial CT) versus all other
SDHs (including subacute, mixed density, or chronic radiological characteristics). Basal cisterns were graded as
either effaced (including both complete and partial effacement) or not effaced. Midline shift was assessed at
the level of the septum pellucidum. Data from clinically
obtained CT angiograms within 4 weeks on incident SDH
were abstracted where available. For patients without
dedicated vascular imaging, MRI T2 flow voids were examined to rule out significant proximal vasospasm. Modified Rankin scales at 3 months were determined by chart
review and were available for all but 1 patient.

Magnetic resonance imaging data
All MRIs were performed on 1.5 Tesla systems
(GE Optima MR450W, GE Signa Explorer, or GE
Signa HDxt; GE Healthcare, Chicago, IL). All images
were initially reviewed by a neuroradiologist. Imaging
reports were reviewed for all patients and marked for
any occurrence of the following phrases: ‘‘restricted diffusion’’; ‘‘acute ischemia’’; or ‘‘hyperintense signal on
diffusion-weighted imaging.’’ Images for all MRIs that
were identified by the above method were then directly
reviewed by a board-certified neurologist (D.R.) to further adjudicate and characterize the cytotoxic edema.
Equivocal cases were reviewed by a second neurologist
(B.F.), and disagreements were resolved by discussion.
The following sequences were reviewed for all patients:
T2 fluid attenuated inversion recovery (T2 FLAIR);
diffusion-weighted imaging (DWI); apparent diffusion
coefficient (ADC); and either gradient echo (GRE) or
susceptibility-weighted angiography (SWAN). Cytotoxic
edema was defined as brain parenchyma that was bright
on DWI and dark on ADC.15 FLAIR and GRE/SWAN sequences were used to evaluate for vasogenic edema and
hemorrhage, respectively.
To be considered SDH-related cytotoxic edema, patients could not have an alternative explanation for the
identified cytotoxic edema (e.g., stroke from cardioembolism, blunt cerebrovascular injury, or large-vessel vasospasm, based on chart review). We also excluded patients
with extensive intraparenchymal hemorrhage in the region of the cytotoxic edema that could confound interpretation.19 Finally, we excluded any patients with cytotoxic
edema in a pattern consistent with diffuse axonal injury
(i.e., punctate lesions at the gray-white border or multifocal lesions in the deep white matter with associated
hemorrhage).20
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Statistical analysis
Descriptive statistics are provided using median (interquartile range; IQR) for all continuous variables (and GCS),
whereas categorical data are presented as number (percentage). Continuous variables were compared using Wilcoxon’s rank-sum test, and Fisher’s exact test was used for
categorical data considering the small sample size. All statistical analyses were conducted in R (version 4.0.2; R
Foundation for Statistical Computing, Vienna, Austria).
A p value of 0.05 was used as the threshold for significance.
Results
Identiﬁcation of the cohort
The study flow diagram is shown in Figure 1. Over the
5-year study period, 4053 SDH patients were identified.
Four hundred fifty (*11%) of these patients received an
MRI within 2 weeks of diagnosis, with restricted diffusion
identified in the reports of 199 cases. Of these 199 cases,
29 patients met all of our criteria for SDH-related cytotoxic edema (*6.5% of all patients receiving an MRI).
Patterns of subdural hematoma–related
cytotoxic edema
MRIs of patients with SDH-related cytotoxic edema were
reviewed in depth and two distinct patterns were identi-
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fied (Fig. 2). In one pattern (N = 19), cytotoxic edema occurred primarily in the cortex near the SDH and not in
traditional vascular distributions (peri-SDH pattern,
shown in Fig. 2A–D). In the other pattern (N = 9), cytotoxic edema occurred distant from the SDH, typically
in the vascular distribution of the ACA, PCA, or watershed regions (ACA/PCA pattern, Fig. 2E,F). Both patterns were identified in 1 patient.
Characteristics of patients with subdural
hematoma–related cytotoxic edema
Comparison of patients with the peri-SDH pattern of cytotoxic edema and the ACA/PCA pattern of cytotoxic
edema are shown in Table 1 (with the patient with both
peri-SDH and ACA/PCA patterns excluded from this
analysis). MRIs were obtained *3.5 days after trauma
or symptom onset in both groups. SDHs in both groups
most commonly had acute radiological characteristics
(58% in the peri-SDH group and 67% in the ACA/PCA
group). Some differences were identified between the
two groups. Patients with the ACA/PCA pattern were
younger (median age of 57 in the ACA/PCA group vs.
71 in the peri-SDH group; p < 0.01), more likely to present with low initial scores on the GCS (median GCS score
of 5 vs. 14; p < 0.01), more likely to have effacement of

FIG. 1. Flow diagram of study. *Includes atherosclerosis, moderate-severe vasospasm, and blunt
cerebrovascular injury from trauma. ICD, International Classiﬁcation of Diseases; IPH, intraparenchymal
hemorrhage; MRI, magnetic resonance imaging; SAH, subarachnoid hemorrhage SDH, subdural hematoma.
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FIG. 2. Patterns of cytotoxic edema. Cytotoxic edema is identiﬁed with green arrows; SDHs are identiﬁed
with red arrows. (A-D) Representative patients with peri-SDH cytotoxic edema. (E,F) Representative patients
with ACA/PCA pattern of cytotoxic edema. ACA, anterior cerebral artery; PCA, posterior cerebral artery; SDH,
subdural hematoma.

their basal cisterns on the initial imaging (100% vs. 42%;
p < 0.01), had more midline shift (14 vs. 6.5 mm;
p = 0.02), were more likely to undergo emergent surgery
(78% vs. 5%; p < 0.01), and more commonly received osmolar therapy (89% vs. 26%; p < 0.01). Seizures were
more common in patients with the peri-SDH pattern
(37% vs. 11%), but this was not statistically significant
( p = 0.21). There was also a non-significant increase in
frequency of subarachnoid hemorrhage in the peri-SDH
cohort (58% vs. 33%). Functional outcome at 3 months,
as assessed by the modified Rankin Scale, was not significantly different between the two groups (median score of
2 in the peri-SDH pattern vs. 4 in the ACA/PCA pattern;
p = 0.47).
Clinical presentation and evaluation of patients
with peri–subdural hematoma cytotoxic edema
Descriptions of all patients with peri-SDH ischemia are
shown in Table 2 (including the patient with both the
peri-SDH and ACA/PCA patterns). Most patients

(80%) had clear focal neurological deficits during their
hospital course. There were waxing and waning symptoms or delayed onset of symptoms after presentation
in 10 of 20 patients (50%). Seizures occurred in 8 patients; among the patients without seizures, 6 of 12
(50%) underwent continuous electroencephalographic
(EEG) monitoring to confirm the absence of ictal abnormalities. Vessel imaging was obtained in 13 of 20 patients (65%), with a median time between the MRI and
vessel imaging of 0 days (IQR, 0, 7). Among these patients, 3 had mild atherosclerosis, 3 had mild vasospasm,
1 had evidence of blunt cerebrovascular injury in a separate territory from the location of the cytotoxic edema,
and 1 had evidence of a prominent superficial vein running through the SDH that was indeterminate as to
whether or not it had thrombosed. Sixteen patients had
long-term follow-up imaging >1 month after presentation; in 10 of these patients, there was evidence of persistent encephalomalacia and/or atrophy at the original site
of cytotoxic edema (Fig. 3).

CYTOTOXIC EDEMA IN SUBDURAL HEMATOMA PATIENTS
Table 1. Comparison of Cohorts with Peri-SDH
and ACA/PCA Patterns of Cytotoxic Edemaa
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Peri-SDH
pattern

ACA/PCA
pattern

No. of patients
19
9
Age, years
71 (58.0, 74.5)
57 (49, 60)
Male sex
8 (42)
7 (78)
Days between initial symptom
3.8 (3.2, 7.3)
3.5 (2.5, 6.5)
onset/trauma and MRI
Initial Glasgow Coma Scale
14 (12.5, 15.0)
5 (3, 6)
Trauma history
13 (68)
7 (78)
Fall <3 feet
10 (53)
3 (33)
3 (16)
4 (44)
High-velocity traumab
Midline shift, mm
6.5 (3.5, 8.5)
14 (7, 16)
Volume, mL
54 (40, 112)
89.5 (65, 131)
Effacement of the basilar cisterns
8 (42)
9 (100)
Acute radiological characteristics 11 (58)
6 (67)
Subacute, mixed, or chronic
8 (42)
3 (33)
radiological characteristics
Subarachnoid hemorrhage
11 (58)
3 (33)
Distant intraparenchymal
7 (37)
5 (56)
hemorrhage
Hyperosmolar treatment
5 (26)
8 (89)
Hypotension (SBP <90 mm Hg)
5 (26)
3 (33)
3 (15)
1 (11)
Hypoxia (SpO2 <88%)
Surgery
7 (37)
9 (100)
Hemicraniectomy
1 (5)
6 (67)
Surgery within 24 h
1 (5)
7 (78)
of presentation
Seizures
7 (37)
1 (11)
Modified Rankin Scale
2 (1, 5)
4 (1, 6)
at 3 months

p
value
<0.01
0.11
0.71
<0.01
1.0
0.43
0.16
0.02
0.14
<0.01
1.0
1.0
0.4
0.44
<0.01
1.0
1.0
<0.01
<0.01
<0.01
0.21
0.47

Data are median (IQR) or n (%), unless otherwise indicated. Bolded values are statistically significant at p < 0.05.
a
Patient with both patterns was excluded from this analysis.
b
Includes motor vehicle collision, pedestrian struck, and falls from >3
feet.
SDH, subdural hematoma; ACA, anterior cerebral artery; PCA, posterior
cerebral artery; MRI, magnetic resonance imaging; SBP, systolic blood
pressure; SpO2, oxygen saturation; IQR, interquartile range.

Discussion
In this large retrospective cohort of SDH patients imaged
with MRI within 2 weeks of incident diagnosis, two distinct patterns of SDH-related cytotoxic edema were identified. In one pattern, cytotoxic edema occurred distant
from the SDH in the vascular territories of the anterior
and posterior cerebral arteries (ACA/PCA pattern). This
pattern predominantly occurred in comatose patients
with significant midline shift and basal cistern effacement. This is consistent with ischemic brain injury
from vascular compression in the setting of cerebral herniation across the falx or tentorium.13,21 In a second and
more common pattern, cytotoxic edema was mostly limited to the cortex near the SDH (peri-SDH pattern). This
peri-SDH pattern was not within a consistent vascular territory and occurred more frequently in non-comatose patients with lesser degrees of midline shift; it also appeared
to be clinically significant, given that it was commonly
associated with focal deficits (80%) and permanent
brain injury on follow-up imaging (63%). This previously
undescribed pattern does not appear to result from cerebral herniation and represents a novel type of secondary
brain injury to target in future studies.
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Cytotoxic edema develops when perturbed cellular
metabolism leads to osmotic expansion of the intracellular space.22 Although our study design cannot determine
the exact mechanism by which this occurred in the periSDH pattern, spreading depolarizations (SDs) are likely
involved. SDs are pathological waves in cerebral gray
matter defined by near-complete breakdown of electrochemical membrane gradients and consequent silencing
of electrical activity (spreading depression).23 Breakdown of the electrochemical gradient leads to cellular
swelling and thus cytotoxic edema.24–26 Although this
is initially reversible,27 SDs are metabolically demanding, and repetitive SDs can lead to critical ischemia
through vasoconstriction from inverse neurovascular
coupling (i.e., spreading ischemia).28 This could lead to
the long-term injury we observed in many patients with
peri-SDH cytotoxic edema.
Several pieces of evidence argue for the importance of
SDs in peri-SDH cytotoxic edema. Rodent SDH models
have found that SDs contribute to cortical lesion development.11 In humans, SDs have been observed in *60% of patients who undergo emergency craniectomy for acute
SDHs29 and contribute to post-operative neurological
deterioration in chronic SDH patients.30 Finally, the periSDH pattern of cytotoxic edema bears a striking resemblance to the laminar infarcts observed in aneurysmal
SAH patients,31–33 which have been attributed to SDs.28
Both SDs34–36 and SDH-induced lesions37,38 are, to a certain
degree, treatable with N-methyl-D-aspartate receptor antagonists, and thus the potential clinical relevance of SDs is considerable; however, further studies are needed to determine
optimal treatments and their impact on outcomes.
Seizures are a related pathophysiology that could also
be involved in the peri-SDH pattern of cytotoxic edema.
Seizures were common among patients with the periSDH cytotoxic edema, and the pattern resembles that
described in some patients with focal seizures.39–41
This observation is consistent with the proposed role of
SDs, given that seizures are observed mainly in patients
with SDs after brain injury.42,43 There are several reasons
why it is unlikely that seizures alone account for the observed cytotoxic edema. First, some of the patients manifested focal weakness days before seizures were
apparent clinically or on EEG. Second, 10 of the periSDH patients had evidence of long-term injury on the
MRI, which is not typical for seizure-related MRI
changes.44 Third, more than half of the patients with the
peri-SDH pattern did not have seizures (with many of
these patients undergoing extensive EEG monitoring), suggesting that other processes are likely necessary to produce
this pattern.
Finally, none of the patients in this study had other
findings typical of seizure-related MRI changes, like restricted diffusion in the thalamus or hippocampus.44
Instead, the isolated neocortical pattern observed in this
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Table 2. Presentation and Evaluation of Patients with the Peri-SDH Pattern of Cytotoxic Edema
Patient
1

Vessel imaging

Presented with contralateral hemiparesis, electrographic seizures
developed on day 5
Presented with encephalopathy, then had GTC and new hemiparesis on
day 2
Presented with hemiparesis
Waxing and waning encephalopathy, isolated GTC
Presented after a fall, developed new aphasia roughly 24 h into admission

2
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3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20a

Seizures EEG

Follow-up Persistent
image
injury

Normal

+

+

No

Not performed

+

+

MRI

–

–
+
–

+
+
+

CT
MRI
MRI

–
–
+

–

+

CT

+

–
+

–
+

MRI
MRI

+
+

–
+

–
+

CT
CT

–
+

–
–
+
–
–
–
+
–
–
+

–
+
+
–
–
–
+
+
+
+

No
CT
MRI
CT
CT
CT
No
No
CT
CT

Not performed
Mild atherosclerosis
Possible small thrombosed
superficial vein in SDH
Waxing and waning encephalopathy
BCVI in wrong
vascular territory
Presented after a fall, developed new hemiparesis on day 3
Not performed
Presented after a fall, developed new hemiparesis on day 3; EEG initially Not performed
negative, but focal motor seizures developed on day 4.
Presented after a fall, developed new hemineglect on day 4
Normal
Presented with encephalopathy, developed new hemiparesis on day 3;
Not performed
EEG initially negative, but focal motor seizures developed
subsequently.
Presented with encephalopathy and hemiparesis
Mild atherosclerosis
Presented after a fall, developed new aphasia on day .
Mild vasospasm
Presented with hemiparesis
Normal
Presented with hemiparesis
Normal
Presented with encephalopathy
Mild vasospasm
Presented with hemisensory changes
Not performed
Presented with focal motor seizure followed by hemiparesis
Normal
Presented with encephalopathy
Mild atherosclerosis
Presented with encephalopathy, developed new aphasia on day 3
Not performed
Presented as comatose, hemiparesis noted after surgical decompression on Mild vasospasm
day 1; focal motor seizures developed on day 4.

+
+
–
+
–
+
+

a

This patient had both the ACA/PCA pattern and the peri-SDH pattern.
GTC, generalized tonic-clonic seizure; SDH, subdural hematoma; BCVI, blunt cerebrovascular injury; CT, computed tomography; MRI, magnetic resonance image; EEG, electroencephalogram; ACA, anterior cerebral artery; PCA, posterior cerebral artery.

study has more commonly been associated with SDs28,45
or with seizures that occur in conjunction with episodes
of systemic hypotension or hypoxia.40,46,47 Systemic hypotension and hypoxia were rare in patients with periSDH cytotoxic edema, but SDHs are known to significantly impair perfusion of the underlying cortex48; although previous studies have suggested that the
resultant hypoperfusion is typically not in the true ischemic range,16,49 borderline hypoperfusion may put these
patients at particular risk for seizure-related injury.
Peri-SDH cytotoxic edema was only identified in 4.5%
of all MRIs and <1% of the overall SDH cohort. This
likely underestimates the true burden of this injury pattern for several reasons. First, relatively few SDH patients received MRIs, and thus cases of cytotoxic
edema may have been missed. Second, MRIs may not
have been optimally timed to detect cytotoxic edema,
given that it could be reversible in some cases27 and in
others could develop in a delayed fashion. Third, we applied relatively strict exclusion criteria. Specifically, we
excluded patients with evidence of diffusion restriction
near a significant intraparenchymal hemorrhage. This
was done because restricted diffusion can occur in the
setting of traumatic contusions,50 but may have led to
the exclusion of some patients who actually had
ischemia-reperfusion injury with hemorrhagic conversion.9 Regardless, our data show that peri-SDH cytotoxic

edema likely does not occur in the majority of SDH patients. There was not an obvious characteristic present
in all patients with the peri-SDH pattern to explain why
many SDH patients do not manifest this form of secondary brain injury. That said, this study is not designed to
determine risk factors, which would be best examined
in a prospective fashion.
There are potential limitations to this study. First, this
study was conducted at a single level 1 trauma center and
thus may be prone to selection bias. For instance, osmotherapy is frequently used in our institution and was common in both cohorts. Although this could affect the
overall incidence of cytotoxic edema and may limit the
generalizability of this study, this should not impact
the distinct patterns that we observed. Second, the retrospective design of our study could bias our population toward severely injured patients, given that they are more
likely to receive MRIs for prognostication. There was little evidence for this in the peri-SDH cohort (median GCS
of 14), but nevertheless our findings will need to be
confirmed prospectively. Third, the use of diffusionweighted MRI to identify cytotoxic edema is potentially
problematic, given that restricted diffusion can be caused
by highly cellular tumors and some infectious processes51; however, this is unlikely to explain our results
given that we excluded patients who were suspected of
having neoplasms or cerebral infections.
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FIG. 3. Representative long-term follow-up images for 2 patients with peri-SDH cytotoxic edema. (A) Initial
diffusion-weighted MRI image shows cytotoxic edema in the right frontal lobe (left panel, red arrow), and
follow-up CT at 2 months shows persistent encephalomalacia (right panel, red arrow). (B) Initial diffusionweighted MRI shows cytotoxic edema in the right lateral temporal lobe (left panel, red arrow), and followup MRI at 1 year shows encephalomalacia and focal atrophy (right panel, red arrow). CT, computed
tomography; MRI, magnetic resonance imaging, SDH, subdural hematoma.

Finally, although patients with evidence of moderatesevere large-vessel vasospasm were excluded from this
study, a role for vasospasm cannot be ruled out given that
1) vessel imaging may not have been timed appropriately
in all cases, and 2) the main method for vessel imaging
(CT angiogram) may be less sensitive for distal spasm.52
Conclusion
SDH-related cytotoxic edema was found in 6.5% of SDH
patients who received an MRI and can occur in two distinct patterns: a peri-SDH pattern that does not clearly
follow vascular territories and an ACA/PCA pattern
that is consistent with vascular compression from hernia-

tion. These results suggest that cytotoxic edema can
occur in SDH patients by multiple mechanisms. Future
research is needed on the mechanism, prevention, and
clinical significance of peri-SDH cytotoxic edema.
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